Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of CS0159 in primary sclerosing cholangitis
CTR20231403Phase 2Active
- Sponsor
- Cascade Pharmaceuticals
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linafexor, sponsored by Cascade Pharmaceuticals. Started Oct 2023; status: active.
02
Drugs
linafexor
Beyond the preview
Go deeper on CTR20231403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231403.